PubMed Health⌕ Search

Biomedical subjects

L A Phebus

Publications and source records attributed to L A Phebus.

29 records · Page 2Linked to original sources

Benzylamine antioxidants: relationship between structure, peroxyl radical scavenging, lipid peroxidation inhibition, and cytoprotection.

Three homologous series of 3,5-dialkoxy-4-hydroxybenzylamines were prepared and tested (1) as peroxyl radical scavengers in homogeneous aqueous solution, (2) as inhibitors of iron-dependent peroxidation of rabbit brain vesicular membrane lipids, and (3) as cytoprotective agents using primary cultures of rat hippocampal neurons exposed to hydrogen peroxide. The structural requirements for efficient radical trapping in homogeneous solution differed from those for effective lipid peroxidation inhibition: In homogeneous solution a kinetic preference existed for smaller, less sterically encumbered substituents flanking the reactive phenolic hydroxyl group. Lipid peroxidation inhibition, on the other hand, required longer more lipophilic substituents. Consequently, a lipophilic alkoxyl substituent at C3 and a small substituent at C5 appeared optimal for efficient radical scavenging activity in both lipid and homogeneous solution. Maximal cytoprotection of rat hippocampal neurons exposed to hydrogen peroxide was also associated with more lipophilic derivatives although substituent length and substituent bulk may represent independent parameters for relating structure and efficacy in this system.

Animals↗

The antioxidant LY231617 reduces global ischemic neuronal injury in rats.

BACKGROUND AND PURPOSE: In the rat four-vessel occlusion model with 30 minutes of ischemia most agents have failed to be of benefit when given after ischemia. Because postischemia administration is more clinically relevant, we evaluated the antioxidant LY231617 (2,6-bis(1,1-dimethylethyl)-4-[[(1-ethyl)amino]methyl]phenol hydrochloride]) when administered after 30 minutes of four-vessel occlusion. METHODS: Male Wistar rats were subjected to 30 minutes of four-vessel occlusion. LY231617 was either given orally 30 minutes before ischemia or intravenously beginning at 30 minutes after the onset of ischemia. Hippocampal CA1 layer and striatal damage were rated on a scale of 0-3 (0, no damage; 3, > 90% cell loss). We also evaluated the ability of LY231617 to prevent iron-dependent lipid peroxidation and to prevent hydrogen peroxide-induced neuronal death of hippocampal neurons in primary culture by exposing cultures to a 50-microM concentration of hydrogen peroxide for 15 minutes in the presence of LY231617. RESULTS: Oral administration of LY231617 reduced both striatal and hippocampal CA1 damage by > 75% (p < 0.0001). In two separate experiments in which LY231617 was given intravenously beginning 30 minutes after occlusion, hippocampal and striatal damage were reduced by approximately 50% (p < 0.03) in the first experiment and by approximately 41% (p < 0.02) in the second experiment. Addition of 5 microM of LY231617 to primary hippocampal neuronal cultures antagonized the lethal effect of hydrogen peroxide (p < 0.05). Iron-dependent lipid peroxidation was also inhibited in a dose-related fashion. CONCLUSIONS: The significant reduction of ischemia-induced or hydrogen peroxide-induced neuronal damage and inhibition of lipid peroxidation by LY231617 observed in this study suggest that reactive oxygen intermediates play an important role in the events leading to neuronal death after global ischemia/reperfusion.

Animals↗

Microdialysis perfusion increases the sensitivity of rat striatal neurons to ischemic insult.

Brief periods of global forebrain ischemia which never produced striatal cell loss in control, non-dialyzed striatum resulted in significant cell loss in the contralateral, dialyzed striatum. No striatal cell loss was seen following these short periods of ischemia in animals implanted with dialysis probes that were not perfused. Dialysis perfusion alters striatal extracellular fluid composition in such a way as to render this tissue more sensitive to brief ischemic insult.

Animals↗

Release of histamine in rat hypothalamus and corpus striatum in vivo.

Histamine has remained a putative neurotransmitter for many years, partially because some of the criteria necessary to define it as a central nervous system neurotransmitter have not been established. The demonstration of in vitro release and the quantification of turnover as an indirect measure of release have been complicated by the histological evidence for multiple histamine pools in the central nervous system. In brain, there are multiple cell types which probably contain histamine. These cells include mast cells, neurolipomastocytoid cells, microvascular endothelial cells, and a histaminergic neuronal system which has been visualized using immunocytochemical methods. Using in situ brain microdialysis and a sensitive and specific radioenzymatic assay for histamine, we have identified histamine in the extracellular space of the rat hypothalamus and corpus striatum in vivo. Following neuronal selective stimuli, significant increases in extracellular histamine levels only were observed in the posterior hypothalamus, where dense histaminergic neuronal terminals have been described. However, after manipulations targeted towards histamine-containing mast cells, such increases were seen in both the posterior hypothalamus and corpus striatum. In summary, this study demonstrates that endogenous histamine can be released from the posterior hypothalamus by stimuli targeted towards histamine neurons and that histamine may also be released by non-neuronal mast cell elements.

Animals↗

Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats.

Systemic administration of direct and indirect dopamine agonists resulted in increased extracellular ascorbic acid levels in the striatum and, to a lesser degree, in the nucleus accumbens as measured by in vivo voltammetry. Intraperitoneal d-amphetamine sulfate (5mg/kg) increased ascorbate concentrations in striatal extracellular fluid. Amphetamine also increased extracellular ascorbate levels in the nucleus accumbens although more gradually and to a lesser extent. Intraperitoneal phenethylamine hydrochloride (20 mg/kg) following pargyline hydrochloride pretreatment (20 mg/kg) increased extracellular ascorbate levels in the striatum significantly above the small increase seen in the nucleus accumbens. The direct acting dopamine agonists Ly-141865 and Ly-163502 when given i.p. at 1 mg/kg, resulted in increased extracellular ascorbate concentrations in both brain areas, again with a significantly greater effect in the striatum. These results indicate that brain extracellular ascorbate levels can be modulated by dopaminergic neuro-transmission and that this modulation is quantitatively different in different dopamine-containing brain structures.

Animals↗

Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites.

Rat striatal extracellular fluid levels of dopamine, serotonin, 3-methoxytyramine (3-MT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured before, during and after transient, global cerebral ischemia in awake rats using in vivo brain microdialysis. Before ischemia, extracellular levels of dopamine, DOPAC, HVA and 5-HIAA were detectable and consistent from sample to sample. During cerebral ischemia, there was a large increase in extracellular dopamine levels and a decrease in the extracellular levels of DOPAC, HVA, and 5-HIAA. During reperfusion, dopamine levels returned to normal as did those of DOPAC, HVA and 5-HIAA. Dialysate serotonin and 3-methoxytyramine concentrations were below detection limits except for samples collected during ischemia and early reperfusion.

3,4-Dihydroxyphenylacetic Acid↗

Dopamine depletion protects striatal neurons from ischemia-induced cell death.

Infusion of the dopamine neurotoxin 6-hydroxydopamine, unilaterally into the substantia nigra of rats, resulted in a unilateral depletion of dopamine in the ipsilateral striatum. When these rats were subjected to global forebrain ischemia by the four-vessel occlusion technique, there was a significant protection of the dopamine depleted striatum from the ischemia-induced loss of medium sized neurons seen in the intact striatum. These results imply a role for dopamine in ischemia-induced striatal cell death.

Animals↗

Brain anoxia releases striatal dopamine in rats.

Immediately following death resulting from discontinuance of artificial respiration in anesthetized rats, a large increase in electrochemically reactive materials in the extracellular fluid was detected by in vivo voltammetry with an electrode in the striatum. The use of in vivo brain dialysis permitted identification of the reactive material as dopamine. The release of dopamine occurred about 6 minutes after cessation of artificial respiration and death. A similar release of dopamine was found after intrastriatal ouabain administration. A large release of dopamine might result in irreversible tissue damage in certain pathological conditions such as stroke or anoxia.

3,4-Dihydroxyphenylacetic Acid↗

Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate.

The first faradiac peak in the voltammogram at +0.12 volts vs an Ag/AgCl reference recorded using a carbon paste working electrode results primarily from the oxidation of extracellular ascorbic acid (AA) with lesser contributions from dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC). The rise in this peak following DA agonist treatment cannot be explained by changes in DA or DOPAC levels since these would be expected to decrease. We carried out brain dialysis and in vivo voltammetry studies in parallel to determine the identity of the substances released into the striatal extracellular fluid by the DA agonist, pergolide, and the dopamine releaser, d-amphetamine.

Animals↗

Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI).

The dopaminergic activity of 4-(2-di-n-propylaminoethyl)indole (DPAI) was investigated. In animal models for postsynaptic dopaminergic activity DPAI showed only very weak or no effects. In rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal tract, very weak contralateral turning behavior was induced in 4/6 rats. DPAI did not induce stereotyped behavior but caused a pronounced reduction in locomotor activity. In male rats pretreated with reserpine, DPAI lowered serum prolactin levels. Levels of homovanillic acid (HVA) were monitored in the striatum of the chloral hydrate anesthetized rat by means of in vivo voltammetry. DPAI administration reduced the faradaic peak corresponding to HVA. In rats pretreated with the decarboxylase inhibitor, NSD-1015, DPAI blocked the accumulation of dopa in response to gamma-butyrolactone. The results of this study indicate that DPAI possesses a high degree of selectivity for presynaptic dopamine autoreceptors, and little or no effect on postsynaptic dopamine receptors.

Animals↗

Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anesthetized vs unanesthetized rats.

Semidifferentiated voltammograms were recorded using graphite paste electrodes in the striatum of the anesthetized and unanesthetized rat treated with the dopamine agonist, pergolide. The first peak in the voltammogram, which represents mainly ascorbic acid (AA) and lesser amounts of dopamine and 3, -4-dihydroxyphenylacetic acid, was decreased in the anesthetized rat and increased in the unanesthetized rat. Spiperone but not alpha-methyltyrosine pretreatment prevented the pergolide-induced rise. Thus, if the first faradaic peak is mainly AA, the release of AA is a postsynaptic dopaminergic event and may be important in dopaminergic neurotransmission.

3,4-Dihydroxyphenylacetic Acid↗